Popular
BlogNEW
CompaniesNEW
Finance
Technology
Banking
Information Technology
Oil and Energy
Internet
Mining and Metals
Communications
Real Estate
Biotechnology
Automotive
Medical
Retail
Energy
23andMe Investor Day Presentation Deck slide image

23andMe Investor Day Presentation Deck

CD96 Program: First Clinical-stage Immuno-oncology Antibody Targeting CD96 Jennifer Low, M.D., Ph.D. Head of Therapeutics Development Strategic Collaboration with gsk Copyright © 2022 23andMe, Inc. 23andMe 43
View entire presentation

Product

HomeSearchAccount

Categories

Finance PresentationsTechnology PresentationsBanking PresentationsInformation Technology PresentationsOil and Energy PresentationsInternet PresentationsMining and Metals PresentationsCommunications PresentationsReal Estate PresentationsBiotechnology PresentationsAutomotive PresentationsMedical PresentationsRetail PresentationsEnergy Presentations

Company

InsightsContactSupport

Legal

Terms of ServicePrivacy Policy

Connect

TwitterLinkedInInstagramYouTube